Ultimately, it is crucial to note that while CD8+ T cells are an essential component of tumor immunity, a number of additional immune cell types have shown prognostic associations in cancer such as FOXP3+ Treg, CD20+ B-TIL as well as myeloid cells such as M1 and M2 macrophages (10). This evidence concerns the gene FOXP3 and cancer.